Synonyms: | |
Status: | Phase 3 |
Entry Type: | Antibody |
Molecule Category: | UNKNOWN |
UNII: | CK1441RCZ8 |
Action | Mechanism of Action | Reference |
---|---|---|
ANTAGONIST | Insulin-like growth factor I receptor antagonist | PubMed |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Ovarian Neoplasms | 2 | D010051 | ClinicalTrials |
Sarcoma, Ewing | 2 | D012512 | ClinicalTrials |
Breast Neoplasms | 2 | D001943 | ClinicalTrials |
Hemangiosarcoma | 2 | D006394 | ClinicalTrials |
Neoplasms | 1 | D009369 | ClinicalTrials |
Carcinoma, Non-Small-Cell Lung | 1 | D002289 | ClinicalTrials |
Rhabdomyosarcoma | 1 | D012208 | ClinicalTrials |
Neoplasms | 1 | D009369 | ClinicalTrials |
Small Cell Lung Carcinoma | 1 | D055752 | ClinicalTrials |
Pancreatic Neoplasms | 1 | D010190 | ClinicalTrials |
Sarcoma | 0 | D012509 | ClinicalTrials |
Resources | Reference |
---|---|
CAS NUMBER | 905703-97-1 |
ChEMBL | CHEMBL1743024 |
FDA SRS | CK1441RCZ8 |